Study directory

ADHD studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1740studies shown
Showing 1-12 of 1,740
Drug study icon
RecruitingNCT06248229

A study of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder (ADHD).

This summary needs review. Please check the official study record and contact the research team for details.

In Rochester Hills
Why is this study shown?

This study is directly about ADHD.

ADHDDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
Rochester Center for Behavioral Medicine
Condition
ADHD
Drug study icon
RecruitingNCT06926829

A Long-term study of EB-1020 in adults with ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In Tokyo
Why is this study shown?

This study is directly about ADHD.

ADHDDrugFrom 18 Years to 55 Years
Countries
Japan
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Condition
ADHD
Drug study icon
RecruitingNCT07087327

A Long-term study of EB-1020 in Pediatric people with ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In Sapporo
Why is this study shown?

This study is directly about ADHD.

ADHDDrugFrom 6 Years to 17 Years
Countries
Japan
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Condition
ADHD
Behavioral study icon
RecruitingNCT06743425

A Study of a Remote ADHD Monitoring Program

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Jackson
Why is this study shown?

This study is directly about ADHD.

ADHDBehavioralFrom 5 Years to 11 Years
Countries
United States
Sponsor
IDeA States Pediatric Clinical Trials Network
Condition
ADHD
Drug study icon
RecruitingNCT07086313

EB-1020 for ADHD

The registry lists this study as recruiting. Study locations are listed in Japan.

In Sapporo
Why is this study shown?

This study is directly about ADHD.

ADHDDrugFrom 6 Years to 17 Years
Countries
Japan
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Condition
ADHD
Drug study icon
RecruitingNCT06931080

EB-1020 for ADHD

The registry lists this study as recruiting. Study locations are listed in Japan.

In Tokyo
Why is this study shown?

This study is directly about ADHD.

ADHDDrugFrom 18 Years to 55 Years
Countries
Japan
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.